24-Aug-2010 - Delivery technology-focused CRO NexMed says it has strengthened its IP position with a new patent award for its NexACT technology from Israeli authorities.
19-Aug-2010 - Midatech and MonoSol Rx have filed a provisional US patent application covering a nanoparticle film drug delivery system for administering biologics.
16-Aug-2010 - Scolr Pharma reduces losses despite drop in revenue by cutting spending on product R&D and operations.
12-Aug-2010 - The US army is funding development of a delivery system for administering pain and infection control drugs to treat battle-related injuries.
11-Aug-2010 - Elan puts plans to sell EDT delivery division on hold because market is not “conducive to an appropriate valuation.”
10-Aug-2010 - Endo Pharmaceuticals will pay $168m (€127.7m) for drug delivery tech and formulations firm Penwest Pharmaceuticals in bid to expand pain portfolio.
09-Aug-2010 - Respiratory formulations specialist Vectura has licensed two dry-formulation technologies to GSK, further strengthening its position in the $25bn (€19bn) asthma and COPD market.
09-Aug-2010 - A Johnson & Johnson (J&J) unit has licensed a gastric retentive drug delivery technology from Depomed for use in a combination therapy.
05-Aug-2010 - Penwest Pharmaceuticals raises guidance citing Opana ER royalties, deals and patent settlements as Q2 highlights; but warns that job cuts likely under cost cutting plan.
04-Aug-2010 - High tech packaging sales and revenue from acquired delivery businesses drive West Pharmaceutical Services growth in second quarter, but US firm cuts guidance.
03-Aug-2010 - FDA draft guidance published this week recommends manufacturers of drug delivery patches adopt QbD to minimise the amount of excess residual drug.
29-Jul-2010 - The medical unit of Becton Dickinson (BD) reported a slight increase in revenues in the third quarter driven by solid sales of diabetes products.
29-Jul-2010 - Marina Biotech has acquired the intellectual property for the Smarticles liposomal-based delivery system from Novosom AG.
21-Jul-2010 - The US FDA is set to make a final approval decision on the one remaining inhalable delivery insulin product, MannKind’s Afrezza, by December 29.
21-Jul-2010 - Pantec Biosolutions AG has secured a CHF20m ($19m) investment to further development of its needle-free in vitro fertilisation (IVF) therapy.
15-Jul-2010 - Encap has announced its DuoCap capsule delivery system has been granted US and European patents that strengthen the firm’s portfolio in the delivery of pharmaceutical active agents that require controlled release.
15-Jul-2010 - Mylan are to acquire Bioniche Pharma’s global injectable pharmaceuticals business for $550m (€430m) in a deal that gives Mylan a significant foothold in meeting product and therapeutic gaps in the US injectables market.
08-Jul-2010 - SurModics has licensed certain elements of its biodegradable polymer implant technology to Clinuvel for use treating sun-induced skin disorders.
06-Jul-2010 - The potential of microbial cells as producers of nanomaterials has been underestimated and further research is needed to improve the situation, according to an academic.
29-Jun-2010 - Sosei has revealed its intention to acquire Activus Pharma in a deal which allows the Japan-based firm to get their hands on Activus' nanoparticle drug formulation tools, a technology that’s in its infancy but holds great potential.
28-Jun-2010 - Regulus Therapeutics’ microRNA satellite technology has won the firm its biggest deal to date with French drugmaker Sanofi-Aventis agreeing a development accord worth up to $750m (€606m).
28-Jun-2010 - Baxter Healthcare is expanding its European R&D presence with a new facility designed to take new pharmaceuticals from “conception to registration.”
24-Jun-2010 - Aphios has been awarded a patent that details an improved process to formulate a polymer-based drug delivery nanotechnology platform. The method offers a more sustainable, consistent administration of therapeutics with less dosage-dependent side effects.
23-Jun-2010 - Schott Pharmaceutical Packaging has revealed details of its US-based ready-to-fill syringe production line capabilities in a manufacturing sector that has traditionally been the strong hold of countries like Germany and France.
16-Jun-2010 - AMRI has acquired Hyaluron for $27m (€22m) to enter the prefilled syringe market and expand the customer base for its existing operations.